Cellular Therapy & Immunobiology Working Party (CTIWP)
Study type:
Study number:
842010
Type of Stem Cell Treatment:
Diseases:
Short title:
DLI after haplo-HSCT
Primary objective:
Key inclusion criteria:
Adults (⩾18 years) with hematological malignancies who received DLI post T replete haplo-SCT in EBMT transplant centres from 2007 to 2017.
Country:
Principal investigator:
Nicole Santoro
EBMT Study coordinator:
Jorinde Hoogenboom
Study coordinator email:
ctiwpebmt@lumc.nl